Pay in 4 interest-free payments of $6.54 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
The break is not required for safety or receptor resensitization, but it allows for reassessment and prevents indefinite use of a compound with limited long-term human data
Its molecular target is nicotinamide N-methyltransferase (NNMT), a cytosolic S-adenosyl-L-methionine-dependent methyltransferase that converts nicotinamide to 1-methylnicotinamide, consuming SAM and releasing S-adenosylhomocysteine
AOD9604 is a synthetic fragment of human growth hormone designed to influence fat metabolism, whereas GLP1 medications like Semaglutide act on gut and brain hormone pathways to reduce appetite and improve blood sugar
Sold strictly for laboratory research use only
Underlying Health Conditions: Conditions like pernicious anemia, Crohns disease, or celiac disease can affect B12 absorption and necessitate ongoing treatment
US$ 24.39
US$ 21.90
US$ 23.15
US$ 24.70
